FocusCalm
PrivateLast Round
Growth Equity
Jan 8, 2026
Est. Valuation
$1.3B
Total Funding Raised
$301.35M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
FocusCalm operates in Healthcare & Life Sciences and is based in Somerville, Massachusetts. Its latest recorded funding round was a Growth Equity round in January 2026.
FocusCalm is a brain-machine interface company that develops wearable EEG headbands and mobile applications for stress management, focus training, and neurofeedback.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical Devices, Consumer Electronics, Sports & Fitness, Health IoT
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FocusCalm Comparables
Compare FocusCalm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrainCo Inc. | 94% | |
| InteraXon Inc. | 86% | |
| Sens.ai Incorporated | 80% |
For institutional investors. Book with your work email.
FocusCalm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jan 8, 2026 | ||||
| Crowdfunding | Dec 16, 2020 | ||||
| Series A | Oct 26, 2017 |
For institutional investors. Book with your work email.
FocusCalm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Growth Equity |
| Walden International | Growth Equity |
| Decent Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 160% MoM, reaching 20.6K.
- Jan 8, 2026
$286M round led by IDG Capital and Walden International.
For institutional investors. Book with your work email.
FocusCalm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FocusCalm's valuation, stock price, and market status.
Is FocusCalm a public or private company?
FocusCalm is a private company.
What is the current stock price of FocusCalm?
FocusCalm is a private company, so its shares have no public market price. Caplight tracks FocusCalm's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FocusCalm worth (valuation)?
FocusCalm's valuation is estimated at $1.3B based on funding round data.
Can I buy FocusCalm stock?
FocusCalm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FocusCalm's last funding round?
FocusCalm's most recent funding round was Growth Equity on January 8, 2026.
Who are the main investors in FocusCalm?
Key investors in FocusCalm include IDG Capital, Walden International.
Will FocusCalm IPO soon?
No public IPO plans have been announced for FocusCalm.
How can I track FocusCalm secondary market activity?
Caplight tracks bids, offers, and trades in FocusCalm's shares on secondary markets.